13F-HR filed by Vivo Capital, LLC
Vivo Capital, LLC filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-15, with 48 holding rows worth $1,441,130,813.
- Accession
- 0001213900-23-039212
- Filer
- CIK 1674712
- Filed
- 2023-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2023
A holdings report, 48 entries on the cover page, a total value of $1,441,130,813 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,441,130,813 with VALUE read as dollars as filed, 13F file number 028-17467. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SINOVAC BIOTECH LTD | P8696W104 | SHS | 5,900,000 | $615,369,410 | dollars as filed | |
| GENETRON HLDGS LTD | 37186H100 | ADS | 8,124,174 | $104,570,306 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 4,249,918 | $85,338,353 | dollars as filed | |
| HARMONY BIOSCIENCES HLDGS IN | 413197104 | COM | 2,606,247 | $85,093,965 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 6,657,992 | $78,830,625 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 1,678,207 | $42,693,586 | dollars as filed | |
| GERON CORP | 374163103 | COM | 19,282,834 | $41,843,750 | dollars as filed | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 3,761,438 | $34,454,772 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 2,262,200 | $28,435,854 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 1,681,199 | $22,359,947 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 579,508 | $21,719,960 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 1,994,941 | $21,525,413 | dollars as filed | |
| CHINOOK THERAPEUTICS INC | 16961L106 | COM | 872,151 | $20,190,296 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 602,075 | $20,169,513 | dollars as filed | |
| VECTIVBIO HLDG AG | H9060V101 | COM | 2,333,300 | $19,856,383 | dollars as filed | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 4,220,048 | $19,074,617 | dollars as filed | |
| ALLAKOS INC | 01671P100 | COM | 4,120,134 | $18,334,596 | dollars as filed | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 416,640 | $13,857,446 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 244,375 | $11,783,763 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 3,556,023 | $11,628,195 | dollars as filed | |
| AMYRIS INC | 03236M200 | COM NEW | 7,750,828 | $10,541,126 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 290,713 | $8,956,868 | dollars as filed | |
| Instil Bio, Inc. | 45783C101 | Common Stock | 12,486,787 | $8,251,269 | dollars as filed | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 1,017,152 | $7,323,494 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 898,631 | $7,269,925 | dollars as filed | |
| SERA PROGNOSTICS INC | 81749D107 | CMN | 1,856,011 | $7,108,522 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 856,008 | $6,728,223 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 577,642 | $6,654,436 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 353,600 | $6,506,240 | dollars as filed | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 509,572 | $6,456,277 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 1,689,515 | $5,862,617 | dollars as filed | |
| IO BIOTECH INC | 449778109 | COM | 3,015,545 | $5,654,147 | dollars as filed | |
| BOLT BIOTHERAPEUTICS INC | 097702104 | COM | 3,871,291 | $5,381,094 | dollars as filed | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 2,708,875 | $4,577,999 | dollars as filed | |
| IMPEL PHARMACEUTICALS INC | 45258K109 | CMN | 2,884,789 | $4,038,705 | dollars as filed | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 655,057 | $4,002,398 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 137,411 | $3,490,239 | dollars as filed | |
| ALIGOS THERAPEUTICS INC COM NEW | 01626L105 | Stock | 3,547,030 | $3,100,104 | dollars as filed | |
| GRACELL BIOTECHNOLOGIES INC | 38406L103 | ADR | 1,463,983 | $2,723,008 | dollars as filed | |
| BIOATLA INC | 09077B104 | COM | 637,181 | $1,707,645 | dollars as filed | |
| ASLAN PHARMACEUTICALS LTD | 04522R101 | ADR | 2,840,909 | $1,636,364 | dollars as filed | |
| CODEXIS INC | 192005106 | COM | 388,144 | $1,606,916 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 550,000 | $1,567,500 | dollars as filed | |
| IMMUNIC INC | 4525EP101 | COM | 632,184 | $941,954 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 489,473 | $939,788 | dollars as filed | |
| MINERVA SURGICAL INC | 60343F106 | COM | 2,215,667 | $486,339 | dollars as filed | |
| TRANSPORTATION & LOGISTI | 438083107 | COM | 370,068 | $381,170 | dollars as filed | |
| PRECISION BIOSCIENCES INC | 74019P108 | COM | 140,255 | $105,696 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001213900-23-039212 | this filing | 2023-05-15 | acceptance time not in the bulk data set |